Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_provenance.
- NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_assertion description "[However vemurafenib, a type I mutant BRAF V600 inhibitor, induces an array of proliferative skin disorders from keratosis pilaris-like and keratoacanthoma-like lesions to locally aggressive cutaneous squamous cell carcinoma (cuSCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_provenance.
- NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_assertion evidence source_evidence_literature NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_provenance.
- NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_assertion SIO_000772 25185693 NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_provenance.
- NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_assertion wasDerivedFrom befree-2016 NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_provenance.
- NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_assertion wasGeneratedBy ECO_0000203 NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1216527.RAzaslB_zj65rDkPJNbK1i5LG3TIKQOS7bgrBPeh-5nUU130_provenance.